PN
PolyNovo Limited
PNV.AX · ASX
$1.03 +0.98% (+$0.01)
1M +17.92%
Market Cap $704.7M
P/E Ratio 95.99x
Div. Yield -
ROE 8.83%
Bulios Fair Price
$0.52
49.5% downside
Trenutna cena
$1.03
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PNV.AX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
4 /100
Expensive P/E 95.99x
EV/EBITDA 49.34x
P/S 4.90x
Growth
97 /100
Growing Rev. growth 30.11%
Book val. growth 11.53%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 32.70%
Net margin 5.11%
Op. margin 7.28%
Quality
53 /100
Average ROIC 8.86%
ROE 8.83%
ROA 5.54%
Debt
99 /100
Low Debt/Equity 0.19x
Current ratio 2.99x
Int. coverage 11.36x
Stability
33 /100
Unstable Beta 1.35x
Rev. volatility 23.70%
EPS volatility 131.10%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PNV.AX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Bruce Peatey
Employees
301
Headquarters
Port Melbourne
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report